I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Hardy-Bessard, A.C
70
results:
Search for persons
X
Format
Online (70)
Mediatypes
Articles (Online) (61)
OpenAccess-fulltext (9)
Languages
english (65)
french (5)
Sorted by: Year
Sorted by: Relevance
?
1
Association between endocrine adjuvant therapy intake timin..:
Giacchetti, Sylvie
;
Laas, Enora
;
Bachelot, Thomas
...
eBioMedicine. 104 (2024) - p. 105141 , 2024
Link:
https://doi.org/10.1016/..
?
2
41MO ESR1 mutation in untreated endometrial cancer: Prevale..:
Blanc-Durand, F.
;
Nikolaev, S.
;
Leman, R.
...
ESMO Open. 9 (2024) - p. 103541 , 2024
Link:
https://doi.org/10.1016/..
?
3
Prognostic value of EndoPredict test in patients with hormo..:
Penault-Llorca, F.
;
Dalenc, F.
;
Chabaud, S.
...
ESMO Open. 9 (2024) 5 - p. 103443 , 2024
Link:
https://doi.org/10.1016/..
?
4
Effective treatment based on monitoring bESR1 mutations – A..:
Bidard, Francois-Clément
;
Hardy-Bessard, Anne-Claire
;
Delaloge, Suzette
The Lancet Oncology. 24 (2023) 1 - p. e4 , 2023
Link:
https://doi.org/10.1016/..
?
5
32O 5-year (y) overall survival (OS) with maintenance olapa..:
Lorusso, D.
;
Mouret-Reynier, M-A.
;
Harter, P.
...
ESMO Open. 8 (2023) 1 - p. 100812 , 2023
Link:
https://doi.org/10.1016/..
?
6
CHEOPS trial: a GINECO group randomized phase II assessing ..:
Bailleux, Caroline
;
Arnaud, Antoine
;
Frenel, Jean-Sébastien
...
Breast Cancer. 30 (2023) 2 - p. 315-328 , 2023
Link:
https://doi.org/10.1007/..
?
7
Updated progression-free survival and final overall surviva..:
Lorusso, Domenica
;
Mouret-Reynier, Marie-Ange
;
Harter, Philipp
...
International Journal of Gynecologic Cancer. 34 (2023) 4 - p. 550-558 , 2023
Link:
https://doi.org/10.1136/..
?
8
Urothelial remodeling after spinal cord injury:
Chapelle, C.
;
Broudeur, L.
;
Bessard, A.
...
European Urology. 83 (2023) - p. S1193 , 2023
Link:
https://doi.org/10.1016/..
?
9
Rucaparib for the Treatment of Metastatic Castration-resist..:
Abida, Wassim
;
Campbell, David
;
Patnaik, Akash
...
European Urology. 84 (2023) 3 - p. 321-330 , 2023
Link:
https://doi.org/10.1016/..
?
10
Recommandations pour la pratique clinique Nice/Saint-Paul-d..:
Martínez, Alejandra
;
Chargari, Cyrus
;
Kalbacher, Elsa
...
Bulletin du Cancer. 110 (2023) 6 - p. 6S20-6S33 , 2023
Link:
https://doi.org/10.1016/..
?
11
Real-Time Detection of ESR1 Mutation in Blood by Droplet Di..:
Callens, Celine
;
Bidard, Francois-Clement
;
Curto-Taribo, Anaïs
...
Analytical Chemistry. 94 (2022) 16 - p. 6297-6303 , 2022
Link:
https://doi.org/10.1021/..
?
12
Paclitaxel with or without pazopanib for ovarian cancer rel..:
Joly, Florence
;
Fabbro, Michel
;
Berton, Dominique
...
Gynecologic Oncology. 166 (2022) 3 - p. 389-396 , 2022
Link:
https://doi.org/10.1016/..
?
13
Efficacy of maintenance olaparib plus bevacizumab according..:
Harter, Philipp
;
Mouret-Reynier, Marie Ange
;
Pignata, Sandro
...
Gynecologic Oncology. 164 (2022) 2 - p. 254-264 , 2022
Link:
https://doi.org/10.1016/..
?
14
Randomised, open-label, multicentric phase III trial to eva..:
Berger, Frédérique
;
Marce, Margaux
;
Delaloge, Suzette
...
BMJ Open. 12 (2022) 3 - p. e055821 , 2022
Link:
https://doi.org/10.1136/..
?
15
Regorafenib or Tamoxifen for platinum-sensitive recurrent o..:
Trédan, Olivier
;
Provansal, Magali
;
Abdeddaim, Cyril
...
Gynecologic Oncology. 164 (2022) 1 - p. 18-26 , 2022
Link:
https://doi.org/10.1016/..
1-15